GlassScriptPhysician profile
Chase Andrew Baxter
NPI 1487145264
$1,565.15
in general payments reported to CMS, 2019-2025
15 companies · $806 in 2025
The $806 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $111 · 2024: $649 · 2025: $806.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,189 · Travel and Lodging: $206 · Education: $59.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,188.79 |
| Travel and Lodging | $205.50 |
| Education | $59.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $337.29 | 2024-2025 | Fasenra, Breztri, Imfinzi |
| Intuitive Surgical, INC. | $316.37 | 2022-2025 | |
| Glaxosmithkline, LLC. | $179.49 | 2024-2025 | Arexvy, Nucala, Trelegy Ellipta |
| Regeneron Healthcare Solutions, INC. | $174.04 | 2024-2025 | Dupixent |
| Genzyme Corporation | $120.14 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.39 | 2024-2025 | Ofev |
| Grifols USA, LLC | $75.09 | 2024-2025 | Prolastin-C Liquid |
| Electromed, INC. | $60.53 | 2024-2025 | Smartvest |
| Sanofi-Aventis U.S. LLC | $59.99 | 2024 | |
| Baxter Healthcare | $34.94 | 2025 | Hillrom - Vest System Model 105 Home Care |
| United Therapeutics Corporation | $23.36 | 2025 | Tyvaso |
| Abbvie INC. | $22.56 | 2025 | |
| Philips North America LLC | $18.32 | 2025 | Encore |
| Viatris Specialty LLC | $17.02 | 2025 | Yupelri |
| Insmed, INC. | $14.62 | 2024 | Arikayce |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chase Baxter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.